news

Third Asian country for Biogenesis Bagó

After recently opening a commercial office in Shanghai and exporting vaccines to South Korea and Taiwan, the pharmaceutical company Biogenesis Bagó continues its international expansion. The company said Vietnam will become the third Asian country to export its anti-fox vaccine, made in Argentina. This country has an area of ​​331,000 square kilometers and 93 million […]

Very strong moment of technological transformation

`The speed of transformation is very strong and there are many displaced who can not find a place`. With this statement, Paolo Rocca, CEO of Techint Group, spoke about the impact of technology on employment last Friday in one of the panels of the annual meeting of the Christian Association of Business Leaders (ACDE). These […]

BIO Fair in San Diego: with mAbxience, we invest in biotechnology

The international biotechnology fair held this month in San Diego, USA, is the most important in the world and seeks to help develop the global biotechnology industry. Local officials traveled there, from where they made some announcements. The first one was the one that made reference to an investment of 120 USD million by Sinergium […]

Monoclonal Antibodies, Mabxience invests in Argentina

Monoclonal antibodies are a type of therapy that in recent years has gained great interest in the effective response it offers to different difficult to treat diseases. The human body constantly generates antibodies, and these are the ones that allow to respond to different infections. By marking the microorganisms that are pathological, they can be […]

The BIO Convention, with an important Argentine presence

Authorities from the Science portfolio participated in the most important international meeting dedicated to biotechnology, including the Minister of Science of the Nation (MINCYT), Lino Barañao, and the undersecretary of Policies in Science, Technology and Productive Innovation, Jorge Aguado , Participated as speakers and attended numerous business meetings at the BIO Convention. The Argentine delegation […]

Insud announces investments in biotechnology for more than 80 million dollars

Grupo Insud, an Argentine business conglomerate present in 40 countries, including Spain, announced investments of more than 80 million dollars for clinical studies in Argentina on state-of-the-art drugs. The announcement was made yesterday at the international biotechnology fair “Bio International Convention”, held in San Diego (USA), and the studies will be conducted by the company […]

$ 80 million for biotechnology in Argentina

mAbxience will begin to develop clinical trials for two monoclonal antibodies: adalimumab, indicated for rheumatoid arthritis and various types of psoriasis; And palivizumab, for the preventive treatment of respiratory syncytial virus (RSV), one of the leading causes of death in infants under one year, according to the World Health Organization. The development of palivizumab is […]

$80 million will be invested for the development of Monoclonal Antibodies in Argentina

Monoclonal antibodies are a type of therapy that in recent years has gained great interest in the effective response it offers to different difficult to treat diseases. The human body constantly generates antibodies, and these are the ones that allow to respond to different infections. By marking the microorganisms that are pathological, they can be […]

More investment in technology

In an international biotechnology fair developed in San Diego, California, the Grupo Insud’s mAbxience firm, and authorities of the National Health Ministry announced yesterday investments of more than US $ 80 million for clinical studies on the latest generation of drugs in Argentina . The initiative coincided with a similar one from Sinergium Biotech, which announced […]

Argentine company to lead a genetic center in China

An Argentine company of the Insud Group will lead in China the construction of a genetic center, with the investment of ten million dollars, to improve the bovine herd of the Asian country: It is the company Garruchos Agropecuaria, owner of Cabaña the Murmullos, that Carries out this initiative in a technology transfer agreement that […]

To sell to China you have to manufacture in China

Biogénesis Bagó, Sebastián Perretta, a specialist who worked on the installation of an anti-foot vaccines plant in the laboratory in Shaanxi province, said that in order to “sell to China it is necessary to produce in China” and augured a very Important for the exports of meat to the Asian country and the development of […]

Argentine bovine genetics arrives in China

Garruchos Agropecuaria de Grupo Insud selló un acuerdo de transferencia tecnológica con la firma asiática Shenlong para mejorar la calidad de la carne del país asiático. La genética argentina, un paso adelante. Garruchos Agropecuaria, a través de su cabaña Los Murmullos, se convirtió en la primera empresa argentina en exportar embriones congelados a China de […]